Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – X-ray contrast imaging agent
Reexamination Certificate
2007-03-13
2007-03-13
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
X-ray contrast imaging agent
C424S009440, C424S009450, C514S345000, C514S358000, C546S290000, C546S300000, C546S329000, C546S346000
Reexamination Certificate
active
10523184
ABSTRACT:
The present invention relates to Halogenated amino acid analogues for use in diagnosis, which compounds have the general formula (I) wherein: R is (C1–C6) alkyl optionally substituted with thioether or ether oxygen atom when n=0, or a substituted aromatic or heteraromatic ring when n=1–6; and m=0 or 1; and X is a halogen atom. The invention further relates to precursor compounds for these analogues, to a method of preparing these analogues, to a pharmaceutical composition comprising these analogues and to the use of these analogues and compositions in the diagnosis of cancer
REFERENCES:
patent: 0 451 422 (1991-10-01), None
patent: 1220591 (1971-01-01), None
patent: 2020275 (1979-11-01), None
patent: WO 03/099746 (2003-12-01), None
Tetrahedron, Sheffer-Dee-Noor et al. 1994, 50(23), 7009-18.
Deehan, B et.al. “Uptake and Distribution of L-3-I-125 Lodo-alpha-methyl tyrosine in exp. rat . . . ” Euro.J.of Nuc. Med., Feb. 1993, p. 101-106,vol. 20, No. 2, Berlin, DE.
Wester H.J. et.al. “Synth. and Radi. of O-(′18F!fluorethyl)-L-tyrosine for tum. imag.”, J. of Nuc. Med.: Off. Publ., Soc. of Nuc.Med.,Jan. 1999,pp. 205-212, vol. 40,No. 1.
Ishiwata K. et.al.:“Synth. and Rad. Dos. of 4-Borono-2-(18F)Fluoro . . . ”, Intl. Jnl. of Rad., Jun. 25, 1990, pp. 325-328, vol. 42, No. 2, Pergamon PressLTD, GB.
Kawai K et. al.“Monoiodo-D-Tyrosine, an artif. Amino Acid . . . ”, Nuc. Med. and Bio., 1990, pp. 369-376, vol. 17, No. 4, Pergamon, Oxford, GB.
Bergstrom, et.al.“PET study of methionine accum. in glioma . . . ”, Jnl of Comp. Assist. Tomagraphy, 1987,pp. 208-213, vol. 11, No. 2,Raven Press, NY.
Coenen, et.al.“Cerebral metabolism of L-2-18F- . . . ”, J. Nucl. Med., Aug. 1989, pp. 1367-1372, vol. 30,No. 8.
Biersack, et. al.“Imaging of brain tumors with L-3-[123I]-iodo . . . ”, J. Nucl. Med., 1989, pp. 110-112, vol. 30.
Jager, P.L.et.al.,“Uptake mechanism of L-3-[125I]iodo-alpha-methyl- . . . ”Nuc. Med. Comm., 2001,pp. 87-96,vol. 22, No. 1, Lippincott Williams & Wilkins.
Lahoutte, et.al.“In vitro charac. of the influx of 3-[125I]iodo- . . . ”, Nuc. Med. of Bio., 2001,pp. 129-134, vol. 28,Elsevier Science Inc.
Heiss, et.al.“Invest. of transport mech. and uptake kinetics of O-2-[18f]fluoroethyl)-L- . . . ”, J. Nuc. Med., 1999,pp. 1367-1373, vol. 40.
Vekeman, et.al.,“L-[2-radioiodo]Tyrosine, a new potential protein synthesis . . . ”,Eur. J. Nuc. Med., 1999, pp. 971, vol. 26, No. 9.
Mertens, et.al.“Uptake study of L-2-I251-o-Tyrosine, . . . ”Eur. J. Nuc. Med.,2000, p. 1063, vol. 27.
Mertens, et.al.“New approach of cell uptake kinetics of L-2-123I-Tyr . . . ”, Eur. J. Nuc. Med. Mol. Imag., 2002, p. S377-P722, vol. 29.
Samnick, et.al.“Initial evaluation on the feasibility of SPECT with p-iodo-Lphenylalanine . . . ”, Nuc. Med. Com., 2002, pp. 121-130, vol. 23, No. 2, Lippincott Williams & Wilkins.
Rau, et.al.“O-(2-[(18)F]Fluoroethyl)-L-tyrosine (FET):a tracer for differentiation . . . ”, Eur. J. Nuc. Med. Mol. Imag., 2002, pp. 1039-1046, vol. 29, No. 8, Springer-Verlag.
Wester, et.al.“Synthesis and Radiopharm.of 0-(2-[18F]fluoroethyl)-L . . . ”, J. Nucl. Med., 1999, pp. 205-212, vol. 40.
Mertens, et.al.“Synthesis, radiosynthesis and in vitro charac . . . ”, Nuc. Med. Bio., 2004, pp. 739-746, vol. 31, Elsevier Inc.
Mertens,et.al.“L-[2-Radioiodo]-Tyrosine a potential tumour tracer for SPECT . . . ”,J. of Label.Comp. and Radiopharm.,May 2001,pp. S860-S862,vol. 44(Suppl. 1).
Hamacher, et.al.“Efficient rountine production of the 18F-labelled . . . ”, Applied Rad. and Isotopes, 2002, pp. 853-856, vol. 40(issue 6), Elsevier Science, Ltd.
Hamacher, et.al.“Convenient synth. of n.c.a. O-(2-[18F]Fluoroethyl)- . . . ”, J. Labelled Cpd. Radiopharm., 2001, p. S855, vol. 44.
Lahoutte, et.al.“Comparative Biodistrib. of Iodinated Amino Acids in Rats . . . ”,Biodistrib.of Iodinated Aminos Acids, 2003, pp. 1489-1494, vol. 44, No. 9.
Chu Yong
Mallinckrodt Inc.
Saeed Kamal A.
LandOfFree
Radioactively labelled amino acid analogues, their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radioactively labelled amino acid analogues, their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radioactively labelled amino acid analogues, their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3785630